These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33899292)

  • 1. Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial.
    Mahjabeen W; Khan DA; Mirza SA; Pervez MA
    Phytother Res; 2021 Jul; 35(7):3968-3976. PubMed ID: 33899292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial.
    Mahjabeen W; Khan DA; Mirza SA
    Complement Ther Med; 2022 Jun; 66():102819. PubMed ID: 35240291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA; Khan DA; Ijaz A; Khan S
    Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Khatami PG; Soleimani A; Sharifi N; Aghadavod E; Asemi Z
    J Clin Lipidol; 2016; 10(4):922-929. PubMed ID: 27578124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepato-Protective Effects of Delta-Tocotrienol and Alpha-Tocopherol in Patients with Non-Alcoholic Fatty Liver Disease: Regulation of Circulating MicroRNA Expression.
    Pervez MA; Khan DA; Gilani STA; Fatima S; Ijaz A; Nida S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ostadmohammadi V; Soleimani A; Bahmani F; Aghadavod E; Ramezani R; Reiter RJ; Mansournia MA; Banikazemi Z; Soleimani M; Zaroudi M; Asemi Z
    J Ren Nutr; 2020 May; 30(3):242-250. PubMed ID: 31597622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delta-tocotrienol supplementation on glycaemic control in individuals with prediabetes: A randomized controlled study.
    Suleman F; Khan DA; Pervez MA; Aamir M
    J Pak Med Assoc; 2022 Jan; 72(1):4-7. PubMed ID: 35099428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Simental-Mendía LE; Majeed M; Sahebkar A
    Drug Res (Stuttg); 2018 Jul; 68(7):403-409. PubMed ID: 29458218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial.
    Pervez MA; Khan DA; Mirza SA; Slehria AUR; Nisar U; Aamir M
    Complement Ther Med; 2022 Nov; 70():102866. PubMed ID: 35933083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: a randomized double-blind controlled trial.
    Moazen S; Amani R; Homayouni Rad A; Shahbazian H; Ahmadi K; Taha Jalali M
    Ann Nutr Metab; 2013; 63(3):256-64. PubMed ID: 24334868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. δ-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial.
    Fatima S; Khan DA; Aamir M; Pervez MA; Fatima F
    Metab Syndr Relat Disord; 2023 Feb; 21(1):25-34. PubMed ID: 36125447
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Asemi Z; Jamilian M; Mesdaghinia E; Esmaillzadeh A
    Nutrition; 2015 Oct; 31(10):1235-42. PubMed ID: 26250486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice.
    Allen L; Ramalingam L; Menikdiwela K; Scoggin S; Shen CL; Tomison MD; Kaur G; Dufour JM; Chung E; Kalupahana NS; Moustaid-Moussa N
    J Nutr Biochem; 2017 Oct; 48():128-137. PubMed ID: 28825992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized double-blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes.
    Ghadimi M; Foroughi F; Hashemipour S; Rashidi Nooshabadi M; Ahmadi MH; Ahadi Nezhad B; Khadem Haghighian H
    Phytother Res; 2021 Feb; 35(2):1023-1032. PubMed ID: 32909365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.
    Pervez MA; Khan DA; Slehria AUR; Ijaz A
    Complement Ther Med; 2020 Aug; 52():102494. PubMed ID: 32951743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial.
    Raygan F; Ostadmohammadi V; Bahmani F; Reiter RJ; Asemi Z
    Clin Nutr; 2019 Feb; 38(1):191-196. PubMed ID: 29275919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Controlled Clinical Trial Investigating the Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Biomarkers of Oxidative Stress, Inflammation and Pregnancy Outcomes in Gestational Diabetes.
    Jamilian M; Hashemi Dizaji S; Bahmani F; Taghizadeh M; Memarzadeh MR; Karamali M; Akbari M; Asemi Z
    Can J Diabetes; 2017 Apr; 41(2):143-149. PubMed ID: 27881297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Maleki V; Alizadeh M; Esmaeili F; Mahdavi R
    Amino Acids; 2020 Jul; 52(6-7):905-914. PubMed ID: 32472292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: A randomized controlled trial.
    Fatima S; Khan DA; Fatima F; Aamir M; Ijaz A; Hafeez A
    Complement Ther Med; 2023 Jun; 74():102950. PubMed ID: 37086927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.